You may know about priority review vouchers (PRV).
Designed by Duke University economists as a means of encouraging drug development for unaddressed tropical diseases, PRVs were made law in 2007.
Essentially, they are transferrable go-to-the-front-of-the-regulatory-line “chits.” And they are awarded to companies that develop approved drugs for certain orphan diseases. Estimates of the financial value of these chits range from $200 million to well over half a billion dollars. They’re like golden tickets.
Mexico City (AFP) - Protesters angry at the apparent massacre of 43 students tried to break into Mexico City's National Palace late Saturday while others torched several trucks in the south of the country.
If Mel Brooks had written his smash show The Producers today, he might be tempted to change the names of the two scheming lead characters from Max Bialystock and Leo Bloom to Garth Drabinsky and Myron Gottlieb.